*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| E261 - Secondary hyperaldosteronism - as a primary or secondary diagnosis code | ||
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | 15.55 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,013,774 | ||||
| Total Hospitalizations with ICD E261 - Secondary hyperaldosteronism | 65 | ||||
| DRG Share of Total Hospitalizations | 3.08 | ||||
| % of Total ICD E261 - Secondary hyperaldosteronism in DRG | 10.69 | ||||
| Avg LOS at DRG | 5.34 | ||||
| Avg LOS with ICD E261 - Secondary hyperaldosteronism | 6.89 | ||||
| Readmission Rate at DRG | 28.25 | ||||
| Readmission Rate with ICD E261 - Secondary hyperaldosteronism | 30.91 | ||||
| Unplanned Readmission Rate at DRG | 21.93 | ||||
| Unplanned Readmission Rate with ICD E261 - Secondary hyperaldosteronism | 27.27 | ||||
| Total Medicare payments at DRG | $9,469,067,156 | ||||
| Total Medicare payments with ICD E261 - Secondary hyperaldosteronism | $636,649 | ||||
| Total Medicare payment per Day at DRG | $1,751 | ||||
| Total Medicare payment per Day with ICD E261 - Secondary hyperaldosteronism | $1,421 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,340 | ||||
| Total Medicare payment per Hospitalization with ICD E261 - Secondary hyperaldosteronism | $9,795 | ||||
| Total Medicare Charges at DRG | $43,343,716,813 | ||||
| Total Medicare Charges with ICD E261 - Secondary hyperaldosteronism | $3,724,530 | ||||
| Avg Charges at DRG | $42,755 | ||||
| Avg Charges with ICD E261 - Secondary hyperaldosteronism | $57,300 | ||||
| Mortality Rate at DRG | 3.72 | ||||
| Mortality Rate with ICD E261 - Secondary hyperaldosteronism | NA | ||||
| SNF Discharge Rate at DRG | 20.84 | ||||
| SNF Discharge Rate with ICD E261 - Secondary hyperaldosteronism | 16.92 | ||||
| Home Discharge Rate at DRG | 37.68 | ||||
| Home Discharge Rate with ICD E261 - Secondary hyperaldosteronism | 41.54 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 432: CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|
| Total Hospitalizations at DRG | 422,757 | ||
| Total Hospitalizations with ICD E261 - Secondary hyperaldosteronism | 23 | ||
| DRG Share of Total Hospitalizations | 1.29 | ||
| % of Total ICD E261 - Secondary hyperaldosteronism in DRG | 3.78 | ||
| Avg LOS at DRG | 4.14 | ||
| Avg LOS with ICD E261 - Secondary hyperaldosteronism | 5.09 | ||
| Readmission Rate at DRG | 24.43 | ||
| Readmission Rate with ICD E261 - Secondary hyperaldosteronism | NA | ||
| Unplanned Readmission Rate at DRG | 18.48 | ||
| Unplanned Readmission Rate with ICD E261 - Secondary hyperaldosteronism | NA | ||
| Total Medicare payments at DRG | $2,636,135,714 | ||
| Total Medicare payments with ICD E261 - Secondary hyperaldosteronism | $137,838 | ||
| Total Medicare payment per Day at DRG | $1,507 | ||
| Total Medicare payment per Day with ICD E261 - Secondary hyperaldosteronism | $1,178 | ||
| Total Medicare payment per Hospitalization at DRG | $6,236 | ||
| Total Medicare payment per Hospitalization with ICD E261 - Secondary hyperaldosteronism | $5,993 | ||
| Total Medicare Charges at DRG | $11,980,955,733 | ||
| Total Medicare Charges with ICD E261 - Secondary hyperaldosteronism | $779,917 | ||
| Avg Charges at DRG | $28,340 | ||
| Avg Charges with ICD E261 - Secondary hyperaldosteronism | $33,909 | ||
| Mortality Rate at DRG | 1.01 | ||
| Mortality Rate with ICD E261 - Secondary hyperaldosteronism | NA | ||
| SNF Discharge Rate at DRG | 16.05 | ||
| SNF Discharge Rate with ICD E261 - Secondary hyperaldosteronism | NA | ||
| Home Discharge Rate at DRG | 47.18 | ||
| Home Discharge Rate with ICD E261 - Secondary hyperaldosteronism | 47.83 |